Conflict of Interest: Nothing to declare.
A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study†
Version of Record online: 21 SEP 2012
Copyright © 2012 Wiley Periodicals, Inc.
Pediatric Blood & Cancer
Volume 60, Issue 4, pages 627–632, April 2013
How to Cite
Blaney, S. M., Tagen, M., Onar-Thomas, A., Berg, S. L., Gururangan, S., Scorsone, K., Su, J., Goldman, S., Kieran, M. W., Kun, L., Boyett, J. and Stewart, C. (2013), A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study. Pediatr. Blood Cancer, 60: 627–632. doi: 10.1002/pbc.24309
- Issue online: 13 FEB 2013
- Version of Record online: 21 SEP 2012
- Manuscript Accepted: 9 AUG 2012
- Manuscript Received: 22 MAY 2012
- 5 U01. Grant Number: CA81457
- NCRR. Grant Number: M01 RR00188
Additional Supporting Information may be found in the online version of this article.
|pbc_24308_sm_SuppFig1.tif||37K||Supplemtary Figure 1.|
|pbc_24308_sm_SuppFig2.tif||874K||Supplemtary Figure 2.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.